Medi Caps

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE442D01010
  • NSEID:
  • BSEID: 523144
INR
32.00
1.23 (4.0%)
BSENSE

Dec 24

BSE+NSE Vol: 2.78 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 723558,
    "name": "Medi Caps",
    "stock_name": "Medi Caps",
    "full_name": "Medi Caps Ltd",
    "name_url": "stocks-analysis/medi-caps",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.00",
    "chg": 1.23,
    "chgp": "4.0%",
    "dir": 1,
    "prev_price": "30.77",
    "mcapval": "38.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 523144,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE442D01010",
    "curr_date": "Dec 24",
    "curr_time": "",
    "bse_nse_vol": "2.78 k",
    "exc_status": "Active",
    "traded_date": "Dec 24, 2025",
    "traded_date_str": "2025 12 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medi-caps-723558-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Medi Caps Stock Falls to 52-Week Low of Rs.28.45 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-stock-falls-to-52-week-low-of-rs2845-amidst-continued-underperformance-3763851",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MediCaps_priceRelatedfactors_3763851.png",
        "date": "2025-12-19 10:07:48",
        "description": "Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.28.45 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial and market performance."
      },
      {
        "title": "Why is Medi Caps falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-medi-caps-fallingrising-3757805",
        "imagepath": "",
        "date": "2025-12-13 01:13:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Despite the slight uptick on 12-Dec, Medi Caps has been under significant pressure over the medium to long term. The stock has declined by 2.35% over the past week, underperforming the Sensex benchmark, which fell by only 0.52% in the same period. More notably, the stock’s one-month return stands at a steep negative 16.14%, contrasting sharply with the Sensex’s positive 0.95% gain. Year-to-date, Medi Caps has suffered a substantial loss of 32.66%, while the Sensex has appreciated by 9.12%. Over the last year, the stock’s decline deepens to 36.94%, whereas the benchmark index has risen by 4.89%. These figures highlight a persistent underperformance relative to the broader market.</p>\n<p>Over longer horizons, the disparity remains pronou..."
      },
      {
        "title": "Medi Caps Sees Revision in Market Assessment Amidst Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medi-caps-downgraded-to-strong-sell-amid-deteriorating-fundamentals-and-bearish-outlook-3750083",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MediCaps_mojoScore_3750083.png",
        "date": "2025-12-07 10:10:21",
        "description": "Medi Caps, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing financial and operational challenges. The recent shift in analytical perspective highlights concerns across multiple performance parameters, underscoring the company’s current position within a competitive and volatile industry landscape."
      },
      {
        "title": "Medi Caps Stock Falls to 52-Week Low of Rs.31 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-stock-falls-to-52-week-low-of-rs31-amidst-continued-underperformance-3749064",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MediCaps_priceRelatedfactors_3749064.png",
        "date": "2025-12-05 13:58:22",
        "description": "Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.31 today, reflecting ongoing challenges in its financial and market performance. The stock's decline contrasts with broader market gains, highlighting persistent pressures on the company’s valuation and operational metrics."
      },
      {
        "title": "Medi Caps Stock Falls to 52-Week Low of Rs.31.91 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-stock-falls-to-52-week-low-of-rs3191-amidst-continued-weakness-3744353",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MediCaps_priceRelatedfactors_3744353.png",
        "date": "2025-12-03 13:48:47",
        "description": "Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low price of Rs.31.91, marking a significant decline in its stock value over the past year. This development comes amid a backdrop of subdued financial performance and persistent challenges reflected in key metrics."
      },
      {
        "title": "Medi Caps Stock Falls to 52-Week Low of Rs.32.03 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-stock-falls-to-52-week-low-of-rs3203-amidst-weak-financial-metrics-3741420",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MediCaps_priceRelatedfactors_3741420.png",
        "date": "2025-12-02 10:00:57",
        "description": "Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.32.03 today, reflecting ongoing challenges in its financial and market performance. This price level marks a significant point for the stock, which has been underperforming relative to key benchmarks over the past year."
      },
      {
        "title": "Medi Caps Stock Falls to 52-Week Low of Rs.32.03 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-stock-falls-to-52-week-low-of-rs3203-amidst-weak-financial-metrics-3741417",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MediCaps_priceRelatedfactors_3741417.png",
        "date": "2025-12-02 10:00:55",
        "description": "Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.32.03 today, reflecting ongoing challenges in its financial and market performance. This decline comes despite a modest gain over the past two days, underscoring persistent pressures on the stock amid broader market dynamics."
      },
      {
        "title": "Medi Caps Stock Falls to 52-Week Low of Rs.33.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-stock-falls-to-52-week-low-of-rs332-amidst-continued-downtrend-3735814",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MediCaps_priceRelatedfactors_3735814.png",
        "date": "2025-11-28 15:07:52",
        "description": "Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.33.2 today, marking a significant point in its ongoing price decline. The stock has experienced a sustained downward trajectory over the past week, reflecting a series of financial and market challenges."
      },
      {
        "title": "Medi Caps Stock Falls to 52-Week Low of Rs.34.25 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-stock-falls-to-52-week-low-of-rs3425-amidst-continued-underperformance-3733686",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MediCaps_priceRelatedfactors_3733686.png",
        "date": "2025-11-27 12:48:34",
        "description": "Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.34.25 today, marking a significant milestone in its recent trading performance. This decline comes amid a backdrop of subdued financial results and persistent challenges reflected in key operational metrics."
      }
    ],
    "total": 81,
    "sid": "723558",
    "stock_news_url": "https://www.marketsmojo.com/news/medi-caps-723558"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2025",
      "details": "Extract of un-audited standalone and consolidated financial results of the company for the quarter/half year ended 30.09.2025 published in free press English edition and choutha sansar Hindi edition dated 14.11.2025. copy of same is attached.",
      "source": "BSE"
    },
    {
      "caption": "Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter As Well As Half Year Ended On 30Th September 2025 Along With Statement Of Assets And Liabilities Cash Flow Statement And Limited Review Report.",
      "datetime": "12-Nov-2025",
      "details": "Unaudited standalone and consolidated financial result of the company for the quarter/half year ended 30 09.2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 12.11.2025.",
      "datetime": "12-Nov-2025",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors at their meeting held on 12th November 2025 has inter alia considered and approved the following businesses: (1) Un-audited Standalone and Consolidated Financial Results of the Company for the quarter as well as half year ended on 30th September 2025 along with Statement of Assets and Liabilities Cash Flow Statement and Limited Review Report thereon. (2) Other routine businesses with the permission of chair. You are requested to please take on record the same.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Medi Caps Ltd has declared <strong>15%</strong> dividend, ex-date: 20 Sep 12",
          "dt": "2012-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Medi Caps Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Mar 13",
          "dt": "2013-03-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Medi Caps falling/rising?

2025-12-13 01:13:49

Recent Price Movement and Market Context

Despite the slight uptick on 12-Dec, Medi Caps has been under significant pressure over the medium to long term. The stock has declined by 2.35% over the past week, underperforming the Sensex benchmark, which fell by only 0.52% in the same period. More notably, the stock’s one-month return stands at a steep negative 16.14%, contrasting sharply with the Sensex’s positive 0.95% gain. Year-to-date, Medi Caps has suffered a substantial loss of 32.66%, while the Sensex has appreciated by 9.12%. Over the last year, the stock’s decline deepens to 36.94%, whereas the benchmark index has risen by 4.89%. These figures highlight a persistent underperformance relative to the broader market.

Over longer horizons, the disparity remains pronou...

Read More
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Nov-2025 | Source : BSE

Extract of un-audited standalone and consolidated financial results of the company for the quarter/half year ended 30.09.2025 published in free press English edition and choutha sansar Hindi edition dated 14.11.2025. copy of same is attached.

Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter As Well As Half Year Ended On 30Th September 2025 Along With Statement Of Assets And Liabilities Cash Flow Statement And Limited Review Report.

12-Nov-2025 | Source : BSE

Unaudited standalone and consolidated financial result of the company for the quarter/half year ended 30 09.2025.

Board Meeting Outcome for Outcome Of Board Meeting Held On 12.11.2025.

12-Nov-2025 | Source : BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors at their meeting held on 12th November 2025 has inter alia considered and approved the following businesses: (1) Un-audited Standalone and Consolidated Financial Results of the Company for the quarter as well as half year ended on 30th September 2025 along with Statement of Assets and Liabilities Cash Flow Statement and Limited Review Report thereon. (2) Other routine businesses with the permission of chair. You are requested to please take on record the same.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Medi Caps Ltd has declared 15% dividend, ex-date: 20 Sep 12

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Medi Caps Ltd has announced 3:1 bonus issue, ex-date: 19 Mar 13

stock-summary
RIGHTS

No Rights history available